0001084577
false
00-0000000
0001084577
2021-12-02
2021-12-02
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of report (Date of earliest event reported):
December 2, 2021
CYREN LTD.
(Exact Name of Registrant as Specified in its Charter)
|
Israel
|
|
000-26495
|
|
Not applicable
|
(State or Other Jurisdiction
of Incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
10 Ha-Menofim St., 5th Floor
Herzliya, Israel
|
|
4672561
|
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
011–972–9–863–6888
(Registrant’s telephone number, including
area code)
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of
the Act:
|
Title of each class
|
|
Trading symbol(s)
|
|
Name of exchange on which
registered
|
|
Ordinary Shares, par value ILS 0.15 per share
|
|
CYRN
|
|
Nasdaq Capital Market
|
Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (§240.12b-2 of this chapter).
|
☐
|
Emerging growth company
|
|
☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
On December 2, 2021, Cyren Ltd. (the “Company”)
paid in full the outstanding principal amount of $10.0 million and accrued but unpaid interest on the unsecured convertible notes (the
“Notes”) issued in December 2018. The Notes matured on December 5, 2021 and were paid in accordance with the terms of the
Notes.
|
Item 9.01
|
Financial Statement and Exhibits.
|
SIGNATURE
Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
CYREN LTD.
|
|
Dated: December 9, 2021
|
|
|
|
|
By:
|
/s/ Kenneth Tarpey
|
|
|
Name:
|
Kenneth Tarpey
|
|
|
Title:
|
Chief Financial Officer
|
Exhibit 99.1
Press Release
Cyren Announces Repayment
of Convertible Notes
Debt Balance reduced
by 52%
McLean, VA – December 9, 2021 –
Today, Cyren Ltd. (NASDAQ:CYRN), a provider of email security and threat intelligence solutions announced that it has paid
in full the outstanding principal amount of $10M, along with accrued interest, on unsecured convertible notes issued in December 2018
with a maturity date of December 5, 2021. The debt payment was funded with cash on hand.
As a result, Cyren reduced its debt balance
by 52%, from approximately $19M to $9M and strengthened its balance sheet.
About Cyren
More than 1.3 billion users around the world
rely on Cyren's cloud security solutions to protect them against cyber-attacks every day. Powered by the world's largest security cloud,
Cyren (NASDAQ: CYRN) delivers fast time-to-protection with embedded threat detection, threat intelligence and email security solutions.
Learn more at www.cyren.com.
This press release contains forward-looking
statements, which may be identified by words such as “expect,” “look forward to,” “anticipate” “intend,”
“plan,” “believe,” “seek,” “estimate,” “will,” “project” or words
of similar meaning. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject
to various known and unknown risks and uncertainties, many of which are beyond Cyren’s control, and cannot be predicted or quantified,
and are detailed from time to time in reports filed by Cyren with the SEC, including quarterly reports on Form 10-Q, reports on Form
8-K and annual reports on Form 10-K. Cyren does not undertake any duty to update any statements contained herein (including any forward-looking
statements), except as required by law.
Company Contact
Kenneth Tarpey, CFO
Cyren
kenneth.tarpey@cyren.com
+1.703.760.3435